Estrella Immunopharma (ESLAW) Stock: Why It's Up Today
Updated Oct 19, 2026, 4:00 PM ET · closing price
- Closed at $0.08, +54.37% vs the prior close of $0.05.
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
Moderna (MRNA)Amgen (AMGN)Gilead Sciences (GILD)Twist Bioscience (TWST)Revolution Medicines (RVMD)Argenx Se (ARGX)
ESLAW jumps 54.4% to $0.08. Closed at $0.08, +54.37% vs the prior close of $0.05. Day range $0.08–$0.08, opened at $0.11.
ESLAW daily analysis — what happened
A plain-English, data-only note for every US trading day (today's note updates every 2 hours while the market is open). Newest first; older days stay archived below.
Oct 19, 2026 — ESLAW jumps 54.4% to $0.08
- Closed at $0.08, +54.37% vs the prior close of $0.05. Day range $0.08–$0.08, opened at $0.11.
- 52-week range $0.05–$0.08; today's close sits at 100% of that range, at a new 52-week high.
ESLAW bull case vs bear case (from the data)
- Insiders made 12 open-market purchases in the last 12 months.
- Latest fiscal-year net income: loss of $13.06M.
- Share count up 17.4% in a year (dilution).
- High volatility: average daily move of 54.4% over 20 sessions.
- Thin trading (under $2M a day on average) can mean wide bid/ask spreads.
ESLAW latest news & SEC filings
Every SEC filing by or about ESLAW in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Sep 8, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 3.01 — Stock exchange listing notice or transfer of listing.
Aug 26, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Aug 25, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Aug 21, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 3.01 — Stock exchange listing notice or transfer of listing.
Aug 14, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 13, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Net income: -$2.31M (prior year -$5.54M) (loss narrowed vs Jun 30, 2025)
- Diluted EPS: -$0.05 (prior year -$0.15) (loss narrowed vs Jun 30, 2025)
Jun 30, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.07 — Reported shareholder vote results.
Things to know before you trade ESLAW
- How much it moves: over the last 20 sessions the average daily move was 54.37% (largest 54.4%). That is a volatile stock.
- Liquidity: about 200 shares (≈$16) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $0.08 vs a range of $0.05–$0.08 (100% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 12 open-market buys, 0 sales; latest: Jiandong Xu bought 1,000 shares on Oct 7, 2025.
- Latest filings: 8-K Sep 8, 2026; 8-K Aug 21, 2026; 10-Q Aug 13, 2026.
- Share count: 43.50M shares outstanding (Aug 11, 2026), +17.4% vs a year earlier — notable dilution.
- Listing: Nasdaq · industry: Biological Products, (No Diagnostic Substances).
ESLAW market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 19, 2026 | 0.11 | 0.08 | 0.08 | 0.08 | 400 |
| Oct 6, 2026 | 0.11 | 0.05 | 0.05 | 0.05 | 0 |
About Estrella Immunopharma
Estrella Immunopharma (ESLAW) is listed on the Nasdaq and classified by the SEC under “Biological Products, (No Diagnostic Substances)”. Its business address is in EMERYVILLE, CA. Fiscal year ends December 31. SEC CIK 1844417.
ESLAW board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Dengyao Jia | Director | Oct 1, 2025 |
| Cheng Liu | CEO | Aug 26, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Cheng Liu | CEO | Aug 26, 2026 |
| Jiandong Xu | Chief Financial Officer | Aug 25, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Oct 7, 2025 | Jiandong Xu | Buy | 1,000 | $1.33 |
| Oct 7, 2025 | Jiandong Xu | Buy | 1,000 | $1.33 |
| Oct 7, 2025 | Jiandong Xu | Buy | 1,000 | $1.33 |
| Oct 7, 2025 | Jiandong Xu | Buy | 1,000 | $1.33 |
| Sep 22, 2025 | Jiandong Xu | Buy | 1,000 | $1.16 |
| Sep 22, 2025 | Jiandong Xu | Buy | 1,000 | $1.16 |
| Sep 22, 2025 | Jiandong Xu | Buy | 1,000 | $1.16 |
| Sep 22, 2025 | Jiandong Xu | Buy | 1,000 | $1.16 |
| Sep 11, 2025 | Jiandong Xu | Buy | 100 | $1.04 |
| Sep 11, 2025 | Jiandong Xu | Buy | 100 | $1.04 |
| Sep 11, 2025 | Jiandong Xu | Buy | 100 | $1.04 |
| Sep 11, 2025 | Jiandong Xu | Buy | 100 | $1.04 |
ESLAW financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | — | $-13.06M | -0.35 | $-1.79M |
| Jun 30, 2024 | — | $-7.31M | -0.27 | $-16.07M |
| Jun 30, 2023 | — | $-11.11M | -36.35 | $-1.34M |
| Dec 31, 2022 | — | $-996.10K | — | $-1.04M |
| Dec 31, 2021 | — | $-247.72K | — | $-316.16K |
Latest balance sheet: total assets $1.82M, total liabilities $9.26M, cash $100.00K (as of Jun 30, 2026).
ESLAW earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| No 8-K earnings releases in recent filings. | ||
Related stocks · Biological Products, (No Diagnostic Substances)
Moderna (MRNA)Amgen (AMGN)Gilead Sciences (GILD)Twist Bioscience (TWST)Revolution Medicines (RVMD)Argenx Se (ARGX)Kodiak Sciences (KOD)Biogen (BIIB)Halozyme Therapeutics (HALO)Vaxcyte (PCVX)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)AMD (AMD)Microsoft (MSFT)Intel (INTC)Amazon (AMZN)
More on ESLAW
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 19, 2026, 4:00 PM ET. Filings: SEC EDGAR. Refreshed every 2 hours during US market hours.